We are live on ! Find out more
HQY icon

HealthEquity

200 hedge funds and large institutions have $2.2B invested in HealthEquity in 2016 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 70 increasing their positions, 57 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 16

91.23% more ownership

Funds ownership: 0%91.23% (+91%)

45% more call options, than puts

Call options by funds: $5.33M | Put options by funds: $3.68M

23% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 57

20% more funds holding

Funds holding: 166200 (+34)

7% more capital invested

Capital invested by funds: $2.06B → $2.2B (+$140M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
200
Holders Change
+34
Holders Change %
+20.48%
% of All Funds
5%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
52
Increased
70
Reduced
57
Closed
16
Calls
$5.33M
Puts
$3.68M
Net Calls
+$1.65M
Net Calls Change
-$5.21M
Name Holding Trade Value Shares
Change
Change in
Stake
TA
76
Teachers Advisors
New York
$3.05M +$259K +6,706 +10%
TIM
77
Thornburg Investment Management
New Mexico
$3.02M -$6.05M -156,516 -68%
SEI Investments
78
SEI Investments
Pennsylvania
$2.92M +$2.78M +71,951 New
Swiss National Bank
79
Swiss National Bank
Switzerland
$2.9M +$135K +3,500 +5%
PP
80
PDT Partners
New York
$2.78M +$788K +20,400 +42%
UBS Group
81
UBS Group
Switzerland
$2.75M +$101K +2,606 +4%
Voloridge Investment Management
82
Voloridge Investment Management
Florida
$2.75M +$2.63M +67,972 New
MCIM
83
Meadow Creek Investment Management
Georgia
$2.74M +$2.62M +67,694 New
Citigroup
84
Citigroup
New York
$2.55M +$1.9M +49,137 +358%
Macquarie Group
85
Macquarie Group
Australia
$2.49M -$264K -6,836 -10%
Citadel Advisors
86
Citadel Advisors
Florida
$2.47M +$2.36M +60,995 New
RhumbLine Advisers
87
RhumbLine Advisers
Massachusetts
$2.37M +$187K +4,829 +9%
RJA
88
Raymond James & Associates
Florida
$2.32M +$2.21M +57,305 New
Canada Life
89
Canada Life
Manitoba, Canada
$2.28M -$39.2K -1,015 -2%
EP
90
Elkfork Partners
Oregon
$2.26M +$2.15M +55,748 New
Bank of America
91
Bank of America
North Carolina
$2.21M +$1.72M +44,402 +432%
Comerica Bank
92
Comerica Bank
Texas
$2.19M +$95.6K +2,474 +6%
RJFSA
93
Raymond James Financial Services Advisors
Florida
$2.11M +$2.01M +52,068 New
LOAMU
94
Lombard Odier Asset Management (USA)
New York
$2.03M +$1.93M +50,000 New
RSCM
95
Rock Springs Capital Management
Maryland
$2.03M +$1.93M +50,000 New
Marshall Wace
96
Marshall Wace
United Kingdom
$1.95M +$1.86M +48,044 New
First Trust Advisors
97
First Trust Advisors
Illinois
$1.87M -$44.3K -1,146 -2%
GHCM
98
Glen Harbor Capital Management
California
$1.77M +$1.69M +43,802 New
AHC
99
Anderson Hoagland & Co
Missouri
$1.72M +$433K +11,210 +36%
FWM
100
Frontier Wealth Management
Missouri
$1.62M -$155K -4,000 -9%

HQY Hedge Fund Activity: Q4 2016 in Review

200 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in HealthEquity (HQY) for Q4 2016, worth a combined $2.2B — up 6.8% from $2.06B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new HQY positions and 16 closed out — a net gain of 36 holders — while 70 added to existing stakes and 57 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $26.3M. The largest seller was W.R. Berkley Corp, cutting an estimated $85.2M.

  • 200 institutional investors held HealthEquity (HQY) as of Q4 2016, up from 166 in Q3 2016.
  • Funds reported $2.2B of HealthEquity stock for Q4 2016, up 6.8% quarter-over-quarter.
  • 52 funds opened new HealthEquity positions in Q4 2016 and 16 closed out, a net change of +36 holders.
  • The largest HealthEquity buyer in Q4 2016 was Fidelity Investments, an estimated $26.3M added.
  • The largest HealthEquity seller in Q4 2016 was W.R. Berkley Corp, an estimated $85.2M sold.

Based on aggregated 13F filings for Q4 2016.